Alport Syndrome Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
ZVSA | F | ZyVersa Therapeutics, Inc. | 2.27 | |
IONS | B | Ionis Pharmaceuticals, Inc. | 1.02 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
ARKG | F | ARK Genomic Revolution Multi-Sector ETF | 4.95 | |
PBE | B | PowerShares Dynamic Biotech & Genome | 3.32 | |
HELX | C | Franklin Genomic Advancements ETF | 2.54 | |
BBP | B | BioShares Biotechnology Products Fund | 1.83 | |
LABD | F | Direxion Daily S&P Biotech Bear 3X Shares | 1.64 |
Compare ETFs
Related Industries:
Biotechnology
- Alport Syndrome
Alport Syndrome is a genetic disorder that affects the kidneys and the ears. It is caused by mutations in the COL4A5 gene, which is responsible for producing type IV collagen, a protein that helps form the basement membrane in the kidneys, inner ear, and eyes. Symptoms of Alport Syndrome include hearing loss, proteinuria (excess protein in the urine), and kidney failure.
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles